Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
The fever, which doctors describe as more severe than is usual in this season, mostly affecting children & adults with comorbidities. No life-threatening case so far, doctors say.
No. of H3N2 cases has doubled since last spike in 2021. Experts say low popularity of flu vaccines, comorbidities & allergens in air can be why people are becoming more susceptible to it.
Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.
French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS